Apellis Pharmaceuticals (APLS) Leases (2020 - 2025)
Historic Leases for Apellis Pharmaceuticals (APLS) over the last 6 years, with Q3 2025 value amounting to $19.7 million.
- Apellis Pharmaceuticals' Leases rose 1559.2% to $19.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.7 million, marking a year-over-year increase of 1559.2%. This contributed to the annual value of $16.1 million for FY2024, which is 395.34% down from last year.
- According to the latest figures from Q3 2025, Apellis Pharmaceuticals' Leases is $19.7 million, which was up 1559.2% from $14.6 million recorded in Q2 2025.
- In the past 5 years, Apellis Pharmaceuticals' Leases registered a high of $22.5 million during Q1 2021, and its lowest value of $14.6 million during Q2 2025.
- In the last 5 years, Apellis Pharmaceuticals' Leases had a median value of $17.9 million in 2023 and averaged $18.2 million.
- In the last 5 years, Apellis Pharmaceuticals' Leases soared by 6929.55% in 2021 and then plummeted by 2068.44% in 2023.
- Apellis Pharmaceuticals' Leases (Quarter) stood at $19.9 million in 2021, then fell by 5.8% to $18.7 million in 2022, then fell by 10.68% to $16.7 million in 2023, then decreased by 3.95% to $16.1 million in 2024, then increased by 22.61% to $19.7 million in 2025.
- Its Leases was $19.7 million in Q3 2025, compared to $14.6 million in Q2 2025 and $15.3 million in Q1 2025.